A fourth Chicago jury failed to award damages to cancer victims suing a manufacturer of over-the-counter heartburn medication Zantac, but the first trial in California is ramping up.
On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer Boehringer Ingelheim, the second in the past two months. Another jury in the same courthouse handed a verdict last month to a separate Zantac manufacturer, GlaxoSmithKline. And, on May 23, a jury sided with both drug manufacturers in the first Zantac trial in the nation.